![](/img/cover-not-exists.png)
Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
Wolk, David A., Sadowsky, Carl, Safirstein, Beth, Rinne, Juha O., Duara, Ranjan, Perry, Richard, Agronin, Marc, Gamez, Jose, Shi, Jiong, Ivanoiu, Adrian, Minthon, Lennart, Walker, Zuzana, Hasselbalch,Language:
english
Journal:
JAMA Neurology
DOI:
10.1001/jamaneurol.2018.0894
Date:
May, 2018
File:
PDF, 268 KB
english, 2018